- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Centre Lists 34 Antimicrobials, Antivirals for Proposed Ban in Animals Under Drugs Act

New Delhi: The Central Government has issued a draft notification proposing the prohibition of import, manufacture, sale, and distribution of a total of 34 antimicrobials and their formulations for animal use, citing risks to human health.
The proposal is outlined in Gazette Notification S.O. 2298(E), dated May 22, 2025, under Section 26A of the Drugs and Cosmetics Act, 1940.
According to the notification, the government is satisfied that the use of these antimicrobials in animals “is likely to involve risk to humans,” and notes that safer veterinary alternatives are available.
The draft was published after consultation with the Drugs Technical Advisory Board (DTAB). DTAB had earlier recommended the prohibition and additionally sought detailed reports from stakeholders on three specific antimicrobials before taking a final view on their inclusion in the ban.
Read Also: DTAB Recommends Ban on 34 Antimicrobials for Animal Use, Seeks Report on 3 Exceptions
Following antimicrobials and group of antimicrobials and their formulations for animal use: -
1. Antibiotics
i. Ureidopenicillins ii. Ceftobiprole iii. Ceftaroline iv. Siderophore cephalosporins v. Carbapenems vi. Penems vii. Monobactams viii. Glycopeptides ix. Lipopeptides x. Oxazolidinones xi. Fidaxomicin xii. Plazomicin xiii. Glycylcyclines xiv. Eravacycline xv. Omadacycline
2. Antivirals
i. Amantadine ii. Baloxavir marboxil iii. Celgosivir iv. Favipiravir v. Galidesivir vi. Lactimidomycin vii. Laninamivir viii. Methisazone/ Metisazone ix. Molnupiravir x. Nitazoxanide xi. Oseltamivir xii. Peramivir xiii. Ribavirin xiv. Rimantadine xv. Tizoxanide xvi. Triazavirin xvii. Umifenovir xviii. Zanamivir
3. Antiprotozoals
i. Nitazoxanide
Objections and suggestions can be submitted within 30 days of publication to the Under Secretary (Drugs), Ministry of Health and Family Welfare, either by post or by email at drugsdiv-mohfw@gov.in.
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751